Books
|
Buy Now
Privileged Scaffolds in Drug Discovery
Loot Price: R5,189
Discovery Miles 51 890
|
|
Privileged Scaffolds in Drug Discovery
Expected to ship within 12 - 17 working days
|
Privileged Scaffolds in Drug Discovery is the most complete
and up-to-date work in the area. Covering a wide
range of privileged structures, it is a perfect reference for
scientists involved in targeted drug development. The editors
recruited epserts from several prestigious Chinese
institutions to cover the areas of antiviral drugs, chalcone,
pyrimidine, (benz)imidazoles, natural product-derived privileged
scaffolds, N-Sulfonyl carboxamides, kinase inhibitors, antitumor
molecules, antineurodegenerative drugs, triazoles, oxazolidinone,
indole and indoline scaffolds, tigliane diterpenoids, peptide and
peptide-based drugs, quassinoids, and others including
pseudonatural products, macrocycles, stable peptides and
peptidomimetics. The book also explores scaffolds in drug
molecules approved in recent years. Privileged Scaffolds in Drug
Discovery is a complete reference for researchers in drug
discovery and organic synthesis, in academic and corporate
settings, who are investigating privileged structures upon
which to base new drugs. Researchers in medicinal chemistry
and chemical biology will also find the contents of this book
valuable.
General
Imprint: |
Academic Press Inc
|
Country of origin: |
United States |
Release date: |
August 2023 |
Editors: |
Bin Yu
• Ning Li
• Caiyun Fu
|
Dimensions: |
276 x 216mm (L x W) |
Pages: |
850 |
ISBN-13: |
978-0-443-18611-0 |
Categories: |
Books
|
LSN: |
0-443-18611-1 |
Barcode: |
9780443186110 |
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.